Objectives

• To present ongoing and planned clinical trials on the role of in- and ex-situ perfusion techniques in liver transplantation.
• The study design and relevant endpoints with their impact on the future routine use of this technology will be in focus.
• Experts with the use of perfusion technology discuss various challenges with clinical trials.

Agenda

• Paolo Muiesan memorial webinars’ introduction – Andrea Schlegel and Gabriela Berlakovich
• Relevant endpoints for clinical trials with machine perfusion – Paulo Martins
• Ongoing and future trials with Normothermic machine perfusion and regional perfusion – Hynek Mergental
• Ongoing and future trials with Hypothermic oxygenated perfusion – Vincent De Meijer
• Q&A moderated by Paulo Martins and Yuri Boteon
• Closing Remarks

This webinar is supported by Bridge to Life

ILTS would like to thank Bridge to Life for their generous support for the production of this webinar. Bridge to Life has had no influence on the content, and full editorial control remains the sole responsibility of ILTS.

Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, Bridge to Life continues to explore emerging science and preservation technologies.